Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus - Wikidata - awgldk - TriplyDB

Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus

Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus

http://www.wikidata.org/entity/Q33766270

about

Lupus pathobiology based on genomics.Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis.Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus Immunopathogenesis of granulomas in chronic autoinflammatory diseases.Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.Changing face of vaccination in immunocompromised hosts.Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins.Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination.A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.

P2860

Q33364409-042A720A-6629-4E80-A267-A9AED99D974B Q34490782-F712BA06-2AD5-455A-805A-C8D31219F843 Q35418255-DB095A80-50EB-4DE7-B4EC-E6E1E5515872 Q35577284-B0AC660E-687C-4F68-9275-96E68DEBF70F Q37538526-106233C4-E40B-4EB8-9EFC-C9BEA4C2C393 Q37715369-9F5375EB-F5F0-4896-B975-922355A31B83 Q38225998-254288BB-2F0B-4EE1-8D0A-A32B0872E58F Q38938727-FA8A8179-BB67-4F27-9AE7-DCCA025FA79B Q40610167-CF761880-17E7-4102-9F7C-F3E51DD129B2 Q41544620-1881CD3B-C84F-4EDE-88DB-9B15C92A7AD9 Q50905754-8D48414B-1C84-4E6E-B0F4-926C4493BB1F

P2860

Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus

http://www.wikidata.org/entity/Q33766270

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Mycophenolic acid counteracts ...... h systemic lupus erythematosus

@ast

Mycophenolic acid counteracts ...... h systemic lupus erythematosus

@en

type

label

Mycophenolic acid counteracts ...... h systemic lupus erythematosus

@ast

Mycophenolic acid counteracts ...... h systemic lupus erythematosus

@en

prefLabel

Mycophenolic acid counteracts ...... h systemic lupus erythematosus

@ast

Mycophenolic acid counteracts ...... h systemic lupus erythematosus

@en

P1433

Q33766270-068830FD-00FF-4FE7-9B65-E45CD6187CCD

P1476

Q33766270-087F7D9D-7BFF-4C35-9594-6C74C2D46136

P2093

Q33766270-2F751F7C-4098-4774-B933-2CBAF494ECC6

Q33766270-3A494ACB-BC89-4852-8567-08556B4C9588

Q33766270-56DCF5A0-C742-4F90-B279-BCDC0F8BEAE4

Q33766270-8069CCDC-1F14-4849-A6A5-F2FA8CB03869

Q33766270-99E07E24-CCAD-4CDD-9D2C-C0D28096C1B6

Q33766270-9E83A554-6F14-428E-8E9C-1907E9C63FF5

P2860

Q33766270-0151D743-04C1-49F2-BE8D-99D63C57B4DC

Q33766270-09DC79D6-C600-4E1F-9CBC-49723B6C7478

Q33766270-0BA6E5C4-ACFD-47DD-B594-61610D934091

Q33766270-0F99387D-6F0C-4399-B19C-5BA71B9E4CB1

Q33766270-10951487-7F53-4358-932B-9FD158AD9451

Q33766270-24EDF75F-95FA-4333-873E-A3DEF3BF2762

Q33766270-3BAAC876-086B-4772-8B45-51DA50DBBE26

Q33766270-3E21959B-9C5B-42BD-AF51-F79B147234C9

Q33766270-3F135807-3544-465F-8EAE-D813102BF3AC

Q33766270-48F58D0C-50BF-43F1-BC7C-2B5A5D31ACC9

P2888

Q33766270-F8331812-F6AC-4C23-AB37-AE180813B996

P304

Q33766270-3D240B38-573E-4D02-9F49-4F65B265A3BF

P31

Q33766270-F430BA6E-9B23-4D37-AEE6-56F9764B6678

P356

Q33766270-A8B4EE03-4618-45B6-8B02-9A3C4CC2F8C3

P433

Q33766270-EB0041BD-C9E5-4357-B7DE-32955C7EAADC

P478

Q33766270-4713D28F-FB0C-4F31-AAEF-34ED1B8BDBF6

P577

Q33766270-CA349E93-0CB2-49FB-8A0D-52381B1801B6

P5875

Q33766270-3EE1702E-0779-4735-A674-6F03E588BD9C

P6179

Q33766270-5ED4EFBC-A102-4871-9CF7-5633B7D774B8

P698

Q33766270-758BE818-7983-4BA1-9F48-CB32F2CDCE76

P932

Q33766270-0027D750-85DA-43C2-BA13-F68E03D3B24B

P356

P1433

Arthritis Research and Therapy

P1476

Mycophenolic acid counteracts ...... h systemic lupus erythematosus

@en

P2093

Annett M Jacobi

http://www.w3.org/2001/XMLSchema#string

Elisabeth Jung

http://www.w3.org/2001/XMLSchema#string

Eva Mickholz

http://www.w3.org/2001/XMLSchema#string

Hermann J Pavenstadt

http://www.w3.org/2001/XMLSchema#string

Jerzy-Roch Nofer

http://www.w3.org/2001/XMLSchema#string

Sebastian Eickenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis

Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration

Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice

Characterization of human type I and type II IMP dehydrogenases

The 1982 revised criteria for the classification of systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?

Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.

B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.

Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis.

P2888

P304

R110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3835

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224931798

http://www.w3.org/2001/XMLSchema#string

P6179

1028465762

http://www.w3.org/2001/XMLSchema#string

P698

22571761

http://www.w3.org/2001/XMLSchema#string

P932

4060361

http://www.w3.org/2001/XMLSchema#string